Update: the Ebola outbreak has reached Kenya, and it came in on a flight
What happened
We wrote last week about Tanzania changing its Ebola screening rules at its borders. This is an update to that story, and a significant one. On Tuesday 6 October 2026, Kenya's Ministry of Health confirmed the country's first case of Ebola disease caused by Bundibugyo virus. Public health teams call this an "imported case". The person did not catch the virus in Kenya. They caught it elsewhere and arrived already infected. The patient was a Kenyan citizen who had been living in the Democratic Republic of the Congo, where this outbreak has run since May. They became ill there, and were treated at several health facilities. On 2 October they travelled by road from DR Congo to Kampala in Uganda, through the town of Beni. On 3 October they flew to Nairobi, and on landing were taken to a hospital in the city and quickly isolated. Two laboratories tested their samples: Kenya's National Virology Reference Laboratory, and the Kenya Medical Research Institute. Both found Bundibugyo virus. The patient died on the night of 5 October, and was buried on 6 October under Kenya's protocol for safe and dignified burials. That protocol exists because funerals have historically been one of the main ways this virus spreads. Kenyan health teams have identified 28 contacts, made up of family members and the health workers who looked after the patient. They are also tracing the other people on the flight into Nairobi: 23 passengers and four crew. Dr Mohamed Janabi, the World Health Organization's Regional Director for Africa, said: "Health emergency preparedness gives us a head start... with rapid and coordinated action, we can prevent the virus from gaining a foothold." Kenya was not starting from scratch. WHO says more than 652,000 travellers had been screened at the country's entry points as of 6 October, 5,000 health workers trained, and isolation units assessed across 27 counties.
Why this matters
Until now, this outbreak has been a Central African emergency. One case does not change its size, but it does change its shape. Kenya does not share a border with DR Congo. The virus did not walk across a frontier. It travelled by road and then by air, through a regional hub, in one person who was already unwell. Nairobi is a major international hub, with direct flights to the UK. That is why this is worth an update rather than another case-count story. It is the first time the outbreak has reached Kenya at all. It is also worth being clear about the scale of what is happening in DR Congo, because the Kenyan case is one person and the outbreak is not. UKHSA reported 8,116 confirmed cases and 3,924 confirmed deaths in DR Congo as of 27 September 2026, across 63 health zones in seven provinces. The European Centre for Disease Prevention and Control put the totals a week later at 8,603 cases and 4,148 deaths, as of 4 October 2026. Uganda recorded 20 confirmed cases, including two deaths, earlier in the year. That outbreak was declared over in late August 2026. So: a very serious epidemic, still growing, has produced its first case in a major regional travel hub.
What the evidence actually says
Three things in the evidence matter more than the headline, and they do not all point the same way. **This is a different virus from the Ebola most people have heard of.** Bundibugyo virus belongs to the Ebola family, but it is not Zaire ebolavirus, which caused the large West African outbreak of 2014 to 2016. That is not a technicality. There is a licensed Ebola vaccine, called Ervebo. It works against Zaire ebolavirus. It has not been shown to protect people against Bundibugyo virus. WHO published emergency guidance on this on 28 May 2026. It found the evidence on whether the vaccine offers any protection against Bundibugyo as well to be very limited, and not enough to estimate how well it might work: the studies that exist are mostly small animal studies and laboratory work, and their findings are inconsistent. On that basis, WHO recommends Ervebo should not be used as a routine response to Bundibugyo outbreaks, outside controlled research settings. In August 2026, WHO and Africa CDC welcomed an allocation of doses to DR Congo: 20,000 for a Phase 3 trial to find out whether the vaccine actually helps against Bundibugyo, and 50,000 for frontline and health workers. So the question is genuinely still open, and is being tested properly rather than assumed. There is also no licensed treatment. According to the National Travel Health Network and Centre, care is supportive, and recovery depends on early care and having symptoms treated. **The disease is severe.** WHO's September report put the case fatality ratio at 48.3%. Roughly 48 people have died for every 100 confirmed cases. This is not a mild illness, and nothing here should suggest otherwise. **The risk to people in the UK is assessed as low.** UKHSA's wording is direct: "The risk of the current outbreak to the UK population is assessed as low." As of 30 September 2026, UKHSA had recorded no imported cases in the UK. ECDC's assessment for Europe is similar: "The risk of importation into the EU/EEA from the outbreak area remains very low." The small number of cases Europe has logged in 2026 were in people infected in Central Africa and treated in isolation, not people who caught the virus here. WHO advises against travel and trade restrictions with the affected countries, based on the information currently available. Two things are true at once. This is a severe and expanding epidemic in Central Africa. It is also, for someone in Lincolnshire with no travel plans, not a reason to change anything today.
Qurexa perspective
We will be straight with you, because the alternative is to stretch a global news story into something it is not. This changes nothing about how we work. It is not a reason to worry about your prescription deliveries, and there is no action we are asking you to take. The honest connection is narrower, and it is about travel rather than outbreaks. If you are heading to the region, the problem you are far more likely to meet is a boring one: running out of a regular medicine while you are away, or coming home to a lapsed repeat prescription. A pharmacy team can sort that out before you go, if you ask early enough. Beyond that, your pharmacist and GP are the right people for travel health questions.
Practical advice
**If you are not travelling, there is nothing you need to do.** That is the accurate answer, and we would rather give it than invent a task for you. **If you are travelling to DR Congo, Uganda, Kenya or the wider region,** check the NaTHNaC country pages on TravelHealthPro and the Foreign, Commonwealth and Development Office advice for your destination. Check before you book, and again shortly before you fly, because this situation is moving. NaTHNaC's advice is to avoid anyone who has symptoms, and to avoid contact with blood and body fluids, and with anything that may have been contaminated with them, such as clothes, bedding or medical equipment. Wash your hands properly and often. That advice tells you how this virus moves. It spreads through direct contact with the body fluids of someone who is ill, or who has died. It does not drift across a room. That is why caring for the sick and preparing bodies for burial are the highest-risk situations. **Sort your regular medicines out before you go.** Order repeat prescriptions in good time, carry them in your hand luggage in the original packaging, and take more than the exact number of days you expect to be away. **If you come back from an affected area and feel unwell, telephone first.** NaTHNaC's advice is to ring your GP, or call NHS 111, rather than turning up at a surgery or walk-in centre. **Tell them where you have been, and when.** NaTHNaC is explicit that returning travellers must give details of recent travel. Say it even if your symptoms seem ordinary, and even if nobody asks. Your travel history is the one thing a clinician cannot work out for themselves.
What to know
Kenya confirmed its first imported Bundibugyo virus case on 6 October 2026. The patient flew into Nairobi on 3 October, was isolated on arrival, and died on 5 October. Kenya is tracing 28 contacts, plus 23 passengers and four crew. The outbreak in DR Congo is large and still growing: 8,116 cases and 3,924 deaths as of 27 September (UKHSA), and 8,603 cases and 4,148 deaths as of 4 October (ECDC). WHO puts the case fatality ratio at 48.3%. The licensed vaccine Ervebo has not been shown to protect against Bundibugyo virus, and a Phase 3 trial is testing whether it helps. There is no licensed treatment. UKHSA assesses the risk to the UK population as low, with no imported cases in the UK as of 30 September 2026. ECDC calls the risk of importation into the EU and EEA very low. If you are travelling to the region, check TravelHealthPro and FCDO advice first. If you return and feel unwell, ring your GP or NHS 111, and tell them where you have been. Sources: World Health Organization Regional Office for Africa, "Kenya confirms first imported Bundibugyo virus disease case; WHO supports control efforts", 6 October 2026, https://afro.who.int/countries/kenya/news/kenya-confirms-first-imported-bundibugyo-virus-disease-case-who-supports-control-efforts | UK Health Security Agency, "Outbreaks under monitoring: week 39 (week ending 27 September 2026)", published 1 October 2026, https://www.gov.uk/government/publications/outbreaks-under-monitoring-in-2026/outbreaks-under-monitoring-week-39-week-ending-27-september-2026 | European Centre for Disease Prevention and Control, "Ebola disease outbreak in the Democratic Republic of the Congo and Uganda", updated October 2026, https://www.ecdc.europa.eu/en/ebola-outbreak-democratic-republic-congo-and-uganda | World Health Organization, "WHO emergency guidance on the use of licensed Ebola virus vaccine during Bundibugyo virus disease outbreaks", 28 May 2026, https://www.who.int/publications/i/item/B09772 | National Travel Health Network and Centre (TravelHealthPro), "Ebola disease", accessed 7 October 2026, https://travelhealthpro.org.uk/diseases/ebola-disease This article is for general information and does not replace advice from a doctor, pharmacist, nurse or other qualified healthcare professional. If you are unwell after travelling, contact your GP or NHS 111 rather than relying on an article.
Related articles
Six hours, not never: the ICU filter notice the MHRA issued today
The UK's medicines and devices regulator has issued a new safety notice to hospitals, and it is about timing. On 13 October 2026 the Medicines and Healthcare p…
Eight pages to a minister: what the data guardian says trust is worth
On 12 October 2026, the government published a letter about who should be trusted with NHS patient data. It was written by Dr Nicola Byrne, the National Data G…
Update: the tests came back, and it was not plague
This is a follow-up to a story we covered on 5 October, when nearly 200 people were being monitored after the death of a laboratory worker in Siberia. There has…